ATOR-1017
Alligator Bioscience’s Q3 is out – comments from the CEO
Swedish Alligator Bioscience recently published its report for the third quarter – a period with significant progress in its...
Alligator Bioscience is ready for an exciting news flow
A lot is going on at Alligator Bioscience....
Alligator Bioscience’s new CMO
Lund-based Alligator Bioscience has several projects in its...
Alligator Bioscience’s CEO looks ahead
Recently, Lund-based Alligator Bioscience delivered its report for...
BioStock Studio: Alligator Bioscience’s CEO on the latest data
Lund-based biotech company Alligator Bioscience recently announced safety...
Allegro Investment Fund about the ownership in Alligator Bioscience
Recently, Allegro Investment Fund exceeded the 25 percent...
Alligator Bioscience on the latest developments
Only a few weeks into the new year...
Alligator Bioscience investerar i sin pipeline
I slutet av tredje kvartalet meddelade det svenska...
Alligator Biosciences vd om nyemissionen
I september meddelade Alligator Bioscience att den första...
BioStock Studio: Alligator Biosciences ordförande om de senaste nyheterna
Lundabaserade Alligator Bioscience meddelade under torsdagen att de...
Alligator har bäddat för fas II med övertecknad emission
Immunonkologibolaget Alligator Bioscience har nu genomfört den kapitalanskaffning...
Alligator genomför kapitalrunda med fokus på fas II
Immunterapibolaget Alligator Bioscience inleder det nya året med...
